Advertisement

Human T-Cell Lymphotropic Virus Type-1 (HTLV-1) Infection in Dermatology

  • Achiléa Lisboa Bittencourt
Chapter

Abstract

Initially, we did a review about the human T-cell lymphotropic virus type-1 (HTLV-1) considering its prevalence, means of transmission, pathogenicity and diagnosis of its infection. Only the HTLV-1-related diseases of dermatological interest are described more extensively, such as infective dermatitis-associated with HTLV-1 (IDH) and adult T-cell leukemia/lymphoma (ATL), diseases occurring in vertically infected carriers. IDH is a severe chronic eczema occurring in childhood and rarely in adults. Progression of IDH to HTLV-1-associated myelopathy and ATL has been reported. ATL is a T-cell leukemia/lymphoma directly related to HTLV-1 that frequently affects the skin as a primary or secondary condition. It has been classified into five types, namely acute, chronic, lymphoma, smoldering and primary cutaneous tumoral (PCT). This classification is essential for treatment decisions and evaluation of prognosis.

Keywords

Human T-cell lymphotropic virus type 1 infection Vertical transmission Crusted scabies Acquired ichthyosis Infective dermatitis associated with HTLV-1 HTLV-1-associated myelopathy/tropical spastic paraparesis Adult T-cell leukemia/lymphoma Primary cutaneous lymphomas Primary cutaneous adult T-cell leukemia/lymphoma Mycosis fungoides 

Notes

Glossary

Acanthosis 

Epidermal hyperplasia (thickening of the epidermis). It implies increased thickness of the (stratum spinosum).

Anaplastic nuclei 

Refers to a group of changes in a cell, loss of polarity (cells may not develop connections to one another), pleomorphism (cells vary in size and shape; their nuclei may also vary in size and shape), hyperchromatism (the nuclei of malignant cells often stain darker than normal cells), abnormal mitoses (division of malignant cells often is abnormal, a feature recognized by “abnormal mitotic figures”) that point to a possible malignant transformation.

Clonal proliferation 

In HTLV-1 infection, is the process in which expansion of infected T cells occur by mitosis. When the proliferation is clonal, the generated cells are identical and all of them have the HTLV-1 provirus integrated in the same site in the host genome. The population of identical infected cells constitutes a clone. Thus, each infected clone can be distinguished from other infected clones by the integration site of the provirus in the host human genome. This process is stimulated by HTLV-1 products.

Crusted scabies 

A rare, highly contagious uncommon form of scabies characterized by presence of huge number of Sarcoptes scabiei in the horny layer of the epidermis. As a reaction, the horny layer thickens and forms warty crusts. In most cases it is associated with some underlying diseases and usually affects immunocompromised patients.

Erythroderma 

Generalized exfoliative dermatitis. It is a disease characterized by erythema and scaling of greater than 90% of the body’s surface.

Folliculotropism and angiotropism 

The invasion of folicular units and vessel walls by lymphocytes. In malignant conditions the lymphocytes show variable degrees of nuclear atypia.

Hyperkeratosis 

Thickening of the horny layer of the skin.

Ichthyosis 

It may be inherited (genetic) or acquired during life. The inherited forms are rare, generally present from infancy, and are usually lifelong conditions. Acquired ichthyosis can develop at any age due to a number of medical problems.

Pagetoid infiltration 

Pagetoid is a term used in dermatology to refer to “upward spreading” of abnormal cells in the epidermis (i.e., from bottom to top). It is a possible indication of a precancerous or cancerous condition.

Parakeratosis 

A mode of keratinization characterized by the retention of nuclei in the stratum corneum. Parakeratosis is associated with the thinning or loss of the granular layer and is usually seen in diseases of increased cell turnover.

Pautrier’s microabscess 

One of the well-defined collections of mycosis cells located within the epidermis in T-cell lymphomas mainly in mycosis fungoides. They are atypical lymphocytes clusters in the epidermis with little associated spongiosis.

Rhinorrhea 

A condition whereby the nasal cavity is filled with a significant amount of mucus fluid. The condition, commonly known as a runny nose, occurs relatively frequently.

Spongiosis 

A microscopic term referring to increased intercellular fluid in the epidermis (intercellular edema) that physically pulls keratinocytes away from each other. If severe, spongiosis will cause intraepidermal vesicles (spongiotic vesicles).

Xerostomy 

Dryness of mucous membranes of the oral cavity and pharynx. It is a consequence of salivary gland dysfunction. Saliva plays an important role in maintaining the correct condition of the oral cavity mucosa.

References

  1. 1.
    Gonçalves DU, Proietti FA, Ribas JG, Araújo MG, Pinheiro SR, Guedes AC, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010 Jul;23(3):577–89.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Bertazzoni U. Editorial to the research topic “Comparative studies between HTLV-1 and HTLV-2 function and pathobiology”. Front Microbiol. 2015 Jan 14;5:792.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Catalan-Soares B, Carneiro-Proietti AB, Proietti FA, Interdisciplinary HTLV Research Group. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saúde Pública. 2005;21(3):926–31.PubMedCrossRefGoogle Scholar
  5. 5.
    Bittencourt AL, Dourado I, Filho PB, Santos M, Valadão E, Alcantara LC, et al. Human T-cell lymphotropic virus type 1 infection among pregnant women in northeastern Brazil. J AIDS. 2001;26(5):490–4.Google Scholar
  6. 6.
    Magalhães T, Mota-Miranda AC, Alcantara LC, Olavarria V, Galvão-Castro B, Rios-Grassi MF. Phylogenetic and molecular analysis of HTLV-1 isolates from a medium sized town in northern of Brazil: tracing a common origin of the virus from the most endemic city in the country. J Med Virol. 2008;80(11):2040–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Mello MA, da Conceição AF, Sousa SM, Alcântara LC, Marin LJ, Regina da Silva Raiol M, et al. HTLV-1 in pregnant women from the Southern Bahia, Brazil: a neglected condition despite the high prevalence. Virol J. 2014;11:28.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Galvão-Castro B, Loures L, Rodriques LG, Sereno A, Ferreira Júnior OC, Franco LG, et al. Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion. 1997;37(2):242–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Dourado I, Alcantara LCJ, Barreto ML, Teixeira MG, Galvão-Castro B. HTLV-1 in the general populationof Salvador, Brazil. A city with African ethnic and socio demographic characteristics. JAIDS. 2003;34(5):527–31.PubMedGoogle Scholar
  10. 10.
    Bittencourt AL. Vertical transmission of HTLV-I/II: a review. Rev Inst Med Trop São Paulo. 1998;40(4):245–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Qayyum S, Choi JK. Adult T-cell leukemia/lymphoma. Arch Pathol Lab Med. 2014;138(2):282–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Oliveira MFSP, Fatal PL, Primo JR, da Silva JL, Batista ES, Farré L, et al. Infective dermatitis associated with human T-cell lymphotropic virus type 1: evaluation of 42 cases observed in Bahia, Brazil. Clin Infect Dis. 2012;54(12):1714–9.CrossRefGoogle Scholar
  13. 13.
    Zihlmann KF, de Alvarenga AT, Casseb J. Living invisible: HTLV-1-infected persons and the lack of care in public health. PLoS Negl Trop Dis. 2012;6(6):e1705.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Lairmore MD, Haines R, Anupam R. Mechanisms of human T-lymphotropic virus type 1 transmission and disease. Curr Opin Virol. 2012;2(4):474–81.PubMedCrossRefGoogle Scholar
  15. 15.
    Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270–80.PubMedCrossRefGoogle Scholar
  16. 16.
    Bangham CR, Ratner L. How does HTLV-1 cause adult T-cell leukemia/lymphoma (ATL)? Curr Opin Virol. 2015;14:93–100.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Bittencourt AL, de Oliveira M. Cutaneous manifestations associated with HTLV-1 infection. Int J Dermatol. 2010;49(10):1099–110.PubMedCrossRefGoogle Scholar
  18. 18.
    Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117(11):3113–22.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    da Silva JL, Primo JR, de Oliveira M, Batista ES, Moreno-Carvalho O, Farré L, et al. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil. J Clin Virol. 2013;58(2):482–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, Alvarez C, et al. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. PLoS Pathog. 2013;9(4):e1003263.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Nascimento MCF, Primo JRL, Bittencourt AL, Siqueira I, Oliveira MFSP, Meyer R, et al. Infective dermatitis has similar immunologic features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Clin Exp Immunol. 2009;156(3):455–62.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Souza A, Tanajura D, Toledo-Cornell C, Santos S, Carvalho EM. Immunopathogenesis and neurological manifestations associated to HTLV-1 infection. Rev Soc Bras Med Trop. 2012;45(5):545–52.PubMedCrossRefGoogle Scholar
  23. 23.
    Dhasmana D, Taylor GP. Human T-lymphotropic virus/HIV coinfection: a clinical review. Curr Opin Infect Dis. 2014;27(1):16–28.PubMedCrossRefGoogle Scholar
  24. 24.
    Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058–68.PubMedCrossRefGoogle Scholar
  25. 25.
    Kamoi K, Mochizuki M. HTLV infection and the eye. Curr Opin Ophthalmol. 2012;23(6):557–61.PubMedCrossRefGoogle Scholar
  26. 26.
    Bittencourt AL. A infecção pelo HTLV-1 na faixa infanto-juvenil. In: HTLV-1. LIVRO HEMOMINAS. vol. XVI, 6ª Ed. Belo Horizonte: Fundação HEMOMINAS; 2015. p. 347–67. Available from: C:/Users/abittencourt/Downloads/livro_htlv-2015.pdf.Google Scholar
  27. 27.
    Bittencourt AL, Vieira MG, Brites C, Farré L, Barbosa HS. Adult T-cell leukemia/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients. Am J Clin Pathol. 2007;128(5):875–82.PubMedCrossRefGoogle Scholar
  28. 28.
    Gonçalves DU, Guedes AC, Carneiro-Proietti AB, Pinheiro SR, Catalan-Soares B, Poietti FA, et al. Simultaneous occurrence of HTLV-I associated myelopathy, uveitis and smouldering adult T cell leukaemia. GIPH (Interdisciplinary HTLV-I/II Research Group). Int J STD AIDS. 1999;10(5):336–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Farré L, de Oliveira MF, Primo J, Vandamme AM, Van Weyenbergh J, Bittencourt AL. Early sequential development of infective dermatitis, human T-cell lymphotropic virus type 1-associated myelopathy, and adult T-cell leukemia/lymphoma. Clin Infect Dis. 2008;46(3):440–2.PubMedCrossRefGoogle Scholar
  30. 30.
    de Bastos ML, Santos SB, Souza A, Finkmoore B, Bispo O, Barreto T, et al. Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis. BMC Infect Dis. 2012;12:199.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Sweet RD. A pattern of eczema in Jamaica. Br J Dermatol. 1966;78(2):93–100.PubMedCrossRefGoogle Scholar
  32. 32.
    La Grenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-1 infection. Lancet. 1990;336(8727):1345–7.CrossRefGoogle Scholar
  33. 33.
    La Grenade L, Manns A, Fletcher V, Derm D, Carberry C, Hanchard B, et al. Clinical, pathologic and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children. Arch Dermatol. 1998;134(4):439–44.PubMedCrossRefGoogle Scholar
  34. 34.
    Tsukasaki K, Yamada Y, Ikeda S, Tomonaga M. Infective dermatitis among patients with ATL in Japan. Int J Cancer. 1994;57(2):293.PubMedCrossRefGoogle Scholar
  35. 35.
    Oliveira PD, Magalhães M, Argolo JM, Bittencourt AL, Farre L. Double integration band of HTLV-1 in a young patient with infective dermatitis who developed an acute form of adult T-cell leukemia/lymphoma. J Clin Virol. 2013;56(2):163–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Araujo AP, Fontenelle LM, Padua PA, Maia Filho HS, Araújo AQ. Juvenile human T lymphotropic virus type 1–associated myelopathy. Clin Infect Dis. 2002;35(2):201–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Lenzi ME, Araujo AQ, Maya TC, Serapião MJ, Leite ACB, Schor D, et al. Dermatite infectiva associada ao HTLV-I: Relato de caso. An Bras Dermatol. 1996;71(2):115–8.Google Scholar
  38. 38.
    Steglich RB, Tonoli RE, Souza PRM, Pinto GM, Riesgo RS. HTLV-1-associated infective dermatitis and probable HTLV-1-associated myelopathy in an adolescent female. An Bras Dermatol. 2015;90(3 Suppl 1):55–8.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Bittencourt AL, Oliveira MFSP, Ferraz N, Vieira MG, Muniz A, Brites C. Adult-onset infective dermatitis associated with HTLV-I. Clinical and immunopathologic aspects of two cases. Eur J Dermatol. 2006;16(1):62–6.PubMedGoogle Scholar
  40. 40.
    Nobre V, Guedes AC, Proietti FA, Martins ML, Nassif G, GIPH (HTLV-1/2 Research Interdisciplinary Group), et al. Increased prevalence of human T cell lymphotropic virus type 1 in patients attending a Brazilian dermatology clinic. Intervirology. 2007;50(4):316–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Maragno L, Casseb J, Fukumori LM, Sotto MN, Duarte AJ, Festa-Neto C, et al. Human T-cell lymphotropic virus type 1 infective dermatitis emerging in adulthood. Int J Dermatol. 2009;48(7):723–30.PubMedCrossRefGoogle Scholar
  42. 42.
    Okajima R, Casseb J, Sanches JA. Copresentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection. Int J Dermatol. 2013;52(1):63–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Di Martino OB, Riveros R, Medina R, Morel M. Infective dermatitis in an adult patient with HTLV-1. Am J Dermatopathol. 2015;37(12):944–8.CrossRefGoogle Scholar
  44. 44.
    Bittencourt AL, Oliveira MFSP, Brites C, Van Weyenbergh J, Vieira MG, Araújo I. Histopathologic and immunohistochemical studies of infective dermatitis associated with HTLV-I. Eur J Dermatol. 2005;15(1):26–30.PubMedGoogle Scholar
  45. 45.
    Hanchard B, La Grenade L, Carberry C, Fletcher V, Williams E, Cranston B, et al. Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years. Lancet. 1991;338(8782–8783):1593–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Gonçalves DU, Guedes AC, Carneiro-Proietti ABF, Lambertucci JR. HTLV-1 associated infective dermatitis may be an indolent HTLV-1 associated lymphoma. Braz J Infect Dis. 2000;4(2):100–2.PubMedGoogle Scholar
  47. 47.
    Bittencourt AL, Barbosa HS, Vieira MG, Farre L. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histologic and immunohistochemical features of 52 cases. Acta Oncol. 2009;48(4):598–604.PubMedCrossRefGoogle Scholar
  48. 48.
    Oliveira MFSP, Vieira MG, Primo J, Siqueira IC, Carvalho EM, Farré L, et al. Flower cells in patients with infective dermatitis associated with HTLV-1. J Clin Virol. 2010;48(4):288–90.CrossRefGoogle Scholar
  49. 49.
    Bittencourt AL, Argolo JM, Oliveira MFSP, Farre L. Infective dermatitis associated with HTLV-1 represents a pre-adult T-cell leukemia/lymphoma (ATLL) condition. In: Annals of the sixty annual T-cell lymphoma forum. San Francisco; 2014.Google Scholar
  50. 50.
    Imaizumi Y, Iwanaga M, Tsukasaki K, Hata T, Tomonaga M, Ikeda S. Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes (“pre-ATL”) in a 20-year follow-up study. Blood. 2005;105(2):903–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Bittencourt AL, Oliveira PD, Andrade AC, Santos TC, Oliveira RF, Farré L, et al. Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil. Am J Clin Pathol. 2013;140(3):348–54.PubMedCrossRefGoogle Scholar
  52. 52.
    Bittencourt AL, Barbosa HS, Requião C, Silva AC, Vandamme AM, Van Weyenbergh J, et al. Adult T-cell leukemia/lymphoma with a mixed CD4+ and CD8+ phenotype and a indolent course. J Clin Oncol. 2007;25(17):2480–2.PubMedCrossRefGoogle Scholar
  53. 53.
    Bittencourt AL, Barbosa HS, Pimenta A, Farré L. A case of adult T-cell leukemia/lymphoma (ATL) with a survival of more than 13 years. Acta Oncol. 2008;47(5):981–3.PubMedCrossRefGoogle Scholar
  54. 54.
    Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–1987). Br J Haematol. 1991;79(3):428–37.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Hanchard B. Adult T-cell leukemia/lymphoma in Jamaica: 1986–1995. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl 1):S20–5.PubMedCrossRefGoogle Scholar
  56. 56.
    Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27(3):453–9.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Yonekura K, Utsunomiya A, Seto M, Takatsuka Y, Takeuchi S, Tokunaga M, et al. Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: comparison between cutaneous type and other subtypes. J Dermatol. 2015;42(12):1143–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Ishitsuka K, Ikeda S, Utsunomiya A, Saburi Y, Uozumi K, Tsukasaki K, et al. Smouldering adult T-cell leukaemia/lymphoma: a follow-up study in Kyushu. Br J Haematol. 2008;143(3):442–4.PubMedCrossRefGoogle Scholar
  59. 59.
    Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al., ATL–Prognostic Index Project. Treatment and survival among 1594 patients with ATL. Blood. 2015;126(24):2570–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Yamaguchi T, Ohshima K, Karube K, Tutiya T, Kawano R, Suefuji H, et al. Clinicopathologic features of cutaneous lesions of adult T-cell leukaemia/lymphoma. Br J Dermatol. 2005;152(1):76–81.PubMedCrossRefGoogle Scholar
  61. 61.
    Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, Kohno T, et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood. 2010;Jun 3;115(22):4337–43.PubMedCrossRefGoogle Scholar
  62. 62.
    Setoyama M, Katahira Y, Kanzaki T. Clinicopathologic analysis of 124 cases of adult T-cell leukemia/lymphoma with cutaneous manifestations: The smouldering type with skin manifestations has a poorer prognosis than previously thought. J Dermatol. 1999;26(12):785–90.PubMedCrossRefGoogle Scholar
  63. 63.
    Oliveira PD, Torres IS, Oliveira RF, Bittencourt AL. Acute adult T-cell leukemia/lymphoma (ATL) presenting with cutaneous purpuric lesions: a rare presentation. Acta Oncol. 2011;50(4):595–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Bittencourt AL, Mota K, Oliveira RF, Farré L. A dyshidrosis-like variant of adult T-cell leukemia/lymphoma with clinicopathologic aspects of mycosis fungoides. A Case Rep Am J Dermatopathol. 2009;31(8):834–7.CrossRefGoogle Scholar
  65. 65.
    Michael EJ, Shaffer JJ, Collins HE, Grossman ME. Bullous adult T-cell lymphoma/leukemia and human T-cell lymphotropic virus-1 associated myelopathy in a 60-year-old man. J Am Acad Dermatol. 2002;46(5 Suppl):S137–41.PubMedCrossRefGoogle Scholar
  66. 66.
    Sawada Y, Hino R, Hama K, Ohmori S, Fueki H, Yamada S, et al. Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma. Blood. 2011;117(15):3961–7.PubMedCrossRefGoogle Scholar
  67. 67.
    Yared JA, Kimball AS. Optimizing management of patients with adult T cell leukemia-lymphoma. Cancers (Basel). 2015;7(4):2318–29.CrossRefGoogle Scholar
  68. 68.
    Tsukasaki K, Imaizumi Y, Tawara M, Fujimoto T, Fukushima T, Hata T, et al. Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV-1 genotype. Br J Haematol. 1999;105(2):369–75.PubMedCrossRefGoogle Scholar
  69. 69.
    Santos JB, Farré L, Batista Eda S, Santos HH, Vieira MD, Bittencourt AL. The importance of flower cells for the early diagnosis of acute adult T-cell leukemia/lymphoma with skin involvement. Acta Oncol. 2010;49(2):265–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Foucar K. Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome. Am J Clin Pathol. 2007;127(4):496–510.PubMedCrossRefGoogle Scholar
  71. 71.
    Burg G, Kempf W, Cozzio A, Feit J, Willemze R, S Jaffe E, et al. WHO/EORTC classification of cutaneous lymphomas 2005: Histologic and molecular aspects. J Cutan Pathol. 2005;32(10):647–74.PubMedCrossRefGoogle Scholar
  72. 72.
    Ohshima K, Jaffe ES, Kikuchi M. Adult T-cell leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO; 2008. p. 281–4.Google Scholar
  73. 73.
    Johno M, Ohishi M, Kojo Y, Yamamoto S, Ono T. Cutaneous manifestations of adult T-cell leukemia/lymphoma. In: Takatsuki K, Hinuma Y, Yoshida M, editors. Advances in adult T-cell leukemia and HTLV-1. Research, Gann monograph on Cancer Research n° 19. Tokyo: Scientific Society Press; 1992. p. 33–42.Google Scholar
  74. 74.
    Amano M, Kurokawa M, Ogata K, Itoh H, Kataoka H, Setoyama M. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types. J Dermatol. 2008;35(5):270–5.PubMedCrossRefGoogle Scholar
  75. 75.
    Miyata T, Yonekura K, Utsunomiya A, Kanekura T, Nakamura S, Seto M. Cutaneous type adult T-cell leukemia/lymphoma is a characteristic subtype and includes erythema/papule and nodule/tumor subgroups. Int J Cancer. 2010;126(6):1521–8.PubMedGoogle Scholar
  76. 76.
    Tsukasaki K, Imaizumi Y, Tokura Y, Ohshima K, Kawai K, Utsunomiya A, et al. Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma. J Dermatol. 2014;41(1):26–8.PubMedCrossRefGoogle Scholar
  77. 77.
    DiCaudo DJ, Perniciaro C, Worrell JT, White JW Jr, Cockerell CJ. Clinical and histologic spectrum of human T-cell lymphotropic virus type I-associated lymphoma involving the skin. J Am Acad Dermatol. 1996;34(1):69–76.PubMedCrossRefGoogle Scholar
  78. 78.
    Sakamoto FH, Colleoni GW, Teixeira SP, Yamamoto M, Michalany NS, Almeida FA, et al. Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma. Int J Dermatol. 2006;45(4):447–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Rueda R, Blank A. HTLV-1 associated cutaneous manifestations. In: Zaninovic V, editor. HTLV, truths and questions. Cali: Feriva; 1996. p. 212–22.Google Scholar
  80. 80.
    Lenzi ME, Cuzzi-Maya T, Oliveira AL, Andrada-Serpa MJ, Araújo AQ. dermatologic findings of human T lymphotropic virus type 1 (HTLV-I) associated myelopathy/tropical spastic paraparesis. Clin Infect Dis. 2003;36(4):507–13.PubMedCrossRefGoogle Scholar
  81. 81.
    Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38(6 Pt 1):877–95.PubMedCrossRefGoogle Scholar
  82. 82.
    Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.PubMedCrossRefGoogle Scholar
  83. 83.
    Bazarbachi A, Plumelle Y, Ramos JC, Tortevoye P, Otrock Z, Taylor G, et al. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol. 2010;28(27):4177–83.PubMedCrossRefGoogle Scholar
  84. 84.
    Sawada Y, Shimauchi T, Yamaguchi T, Okura R, Hama-Yamamoto K, Fueki-Yoshioka H, et al. Combination of skin-directed therapy and oral etoposide for smoldering adult T-cell leukemia/lymphoma with skin involvement. Leuk Lymphoma. 2013;54(3):520–7.PubMedCrossRefGoogle Scholar
  85. 85.
    Marçais A, Suarez F, Sibon D, Frenzel L, Hermine O, Bazarbachi A. Therapeutic options for adult T-cell leukemia/lymphoma. Curr Oncol Rep. 2013;15(5):457–64.PubMedCrossRefGoogle Scholar
  86. 86.
    Kudo H, Fukushima S, Masuguchi S, Sakai K, Jinnin M, Ihn H. Cutaneous type adult T-cell leukaemia/lymphoma successfully treated with narrowband ultraviolet B phototherapy. Clin Exp Dermatol. 2012;37(2):183–4.PubMedCrossRefGoogle Scholar
  87. 87.
    Germain M, Williams J, Skelton HG, Smith KJ. Smoldering HTLV-1-induced T-cell lymphoma localized within the skin; a radiation-resistant tumor. Int J Dermatol. 2000;39(11):815–21.PubMedCrossRefGoogle Scholar
  88. 88.
    Takahashi K, Tanaka T, Fujita M, Horiguchi Y, Miyachi Y, Imamura S. Cutaneous-type adult T-cell leukemia/lymphoma. A unique clinical feature with monoclonal T-cell proliferation detected by Southern blot analysis. Arch Dermatol. 1988;124(3):399–404.PubMedCrossRefGoogle Scholar
  89. 89.
    Shimizu S, Yasui C, Koizumi K, Ikeda H, Tsuchiya K. Cutaneous-type adult T-cell leukemia/lymphoma presenting as a solitary large skin nodule: a review of the literature. J Am Acad Dermatol. 2007;57(5 Suppl):S115–7.PubMedCrossRefGoogle Scholar
  90. 90.
    Lyra-da-Silva JO, de Mello Gonzaga YB, de Melo EO, de Andrada-Serpa MJ, Dib C, et al. Adult T-cell leukemia/lymphoma: a case report of primary cutaneous tumoral type. Dermatol Pract Concepts. 2012;2(2):202–3.Google Scholar
  91. 91.
    Milagres SP, Sanches JA Jr, Milagres AC, Valente NY. Histopathologic and immunohistochemical assessment of acquired ichthyosis in patients with human T-cell lymphotropic virus type I-associated myelopathy. Br J Dermatol. 2003;149(4):776–81.PubMedCrossRefGoogle Scholar
  92. 92.
    Hashiguchi T, Osame M, Arimura K. Skin manifestations in HTLV-1 associated myelopathy (HAM): xerosis and erythema. In: HTLV-1 and the nervous system. Manhattan: Alan R Liss; 1989. p. 443–8.Google Scholar
  93. 93.
    Yamaguchi K. Human T-cell lymphotropic virus type I in Japan. Lancet. 1994;343(8891):213–6.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Gonçalves DU, Guedes AC, Proietti AB, Martins ML, Proietti FA, Lambertucci JR, et al., Interdisciplinary HTLV-1/2 Research Group. Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1. Am J Trop Med Hyg. 2003;68(5):562–5.Google Scholar
  95. 95.
    Setoyama M, Mizoguchi S, Eizuru Y. Human T-cell lymphotropic virus type I infects eccrine sweat gland epithelia. Int J Cancer. 1999;80(5):652–5.PubMedCrossRefGoogle Scholar
  96. 96.
    Maloney EM, Wiktor SZ, Palmer P, Cranston B, Pate EJ, Cohn S, et al. A cohort study of health effects of human T-cell lymphotropic virus type I infection in Jamaican children. Pediatrics. 2003;112(2):e136–42.PubMedCrossRefGoogle Scholar
  97. 97.
    Brites C, Weyll M, Pedroso C, Badaró R. Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-1) infection in Bahia, Brazil. AIDS. 2002;16(9):1292–3.PubMedCrossRefGoogle Scholar
  98. 98.
    Tseng CT, Sell S. Protracted treponema pallidum-induced cutaneous chancres in rabbits infected with human T-cell leukemia virus type I. AIDS Res Hum Retrovir. 1991;7(3):323–31.PubMedCrossRefGoogle Scholar
  99. 99.
    Carnaúba D Jr, Bittencourt A, Brites C. Atypical presentation of syphilis in an HTLV-I infected patient. Braz J Infect Dis. 2003;7(4):273–7.PubMedCrossRefGoogle Scholar
  100. 100.
    Machado PR, Machado LM, Shibuya M, Rego J, Johnson WD, Glesby MJ. Viral coinfection and leprosy outcomes: a cohort study. PLoS Negl Trop Dis. 2015;9(8):e0003865.PubMedPubMedCentralCrossRefGoogle Scholar

Suggestions ReadingIn Portuguese

  1. HTLV-1. LIVRO HEMOMINAS, vol. XVI, 6ª Ed. Belo Horizonte, Fundação HEMOMINAS, 2015. Available from: C:/Users/abittencourt/Downloads/livro_htlv-2015.pdf.Google Scholar
  2. Oliveira PD, Farre L, Bittencourt AL. Leucemia/linfoma de células T do adulto. Revisão. Rev Ass Méd Bras. Aceito para publicação.Google Scholar
  3. Bittencourt AL, Farré L. Vírus linfotrópico para células T humanas tipo 1 (HTLV-1). Capítulo 32. In: Brasileiro Filho G, editor. Bogliolo, Patologia. 8ª edição ed. Rio de Janeiro: Guanabara Koogan; 2011. p. 1357–68.Google Scholar
  4. Bittencourt AL, Farré L. Leucemia/linfoma de células T do adulto. Adult T-cell leukemia/lymphoma. An Bras Dermatol. 2008;83:351–9.CrossRefGoogle Scholar
  5. Bittencourt AL, Oliveira MFSP. Dermatite Infecciosa associada ao HTLV-1- Revisão. An Bras Dermatol. 2001;76:723–32.Google Scholar

In English

  1. Bangham CR, Cook LB, Melamed A. HTLV-1 clonality in adult T-cell leukaemia and nonmalignant HTLV-1 infection. Semin Cancer Biol. 2014;26:89–98.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Cook LB, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L, et al. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. Blood. 2014;123(25):3925–31.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30(8):837–42.PubMedCrossRefGoogle Scholar
  4. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25(34):5458–64.PubMedCrossRefGoogle Scholar
  5. Tsukasaki K, Tobinai K. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research. Clin Cancer Res. 2014;20(20):5217–25.PubMedCrossRefGoogle Scholar
  6. Utsunomiya A, Choi I, Chihara D, Seto M. Recent advances in the treatment of adult T-cell leukemia-lymphomas. Cancer Sci. 2015;106(4):344–51.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  1. 1.Pathology Department, Complexo Hospitalar Universitario Prof. Edgard SantosSalvador BahiaBrazil

Personalised recommendations